Pulik Richard (CIK 1885841) reported 23 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-22). Recent activity: Sell ROIV (2,129 shares), Sell ROIV (5,749 shares), Sell ROIV (2,129 shares), Sell ROIV (18,962 shares), Buy ROIV (60,644 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-22 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,129 | $84,670 |
| 2026-08-24 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 5,749 | $211,793 |
| 2026-06-23 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,129 | $66,914 |
| 2026-05-22 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 18,962 | $614,558 |
| 2026-04-22 | Roivant Sciences Ltd. (ROIV) | CFO | Buy | 60,644 | $0 |
| 2026-03-24 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,546 | $42,824 |
| 2026-02-24 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,000 | $27,150 |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | CFO | Buy | 260,000 | $1.0M |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 260,000 | $5.8M |
| 2025-12-29 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 146,731 | $3.3M |
| 2025-12-23 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,129 | $47,711 |
| 2025-11-24 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,235 | $25,033 |
| 2025-09-30 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,341 | $35,513 |
| 2025-09-23 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,129 | $32,020 |
| 2025-09-02 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 2,340 | $27,940 |
| 2025-08-22 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,235 | $14,474 |
| 2025-07-30 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,919 | $21,781 |
| 2025-07-01 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,653 | $18,828 |
| 2025-06-24 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,503 | $17,209 |
| 2025-05-30 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,653 | $17,555 |
| 2025-05-22 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 3,487 | $38,496 |
| 2025-04-30 | Roivant Sciences Ltd. (ROIV) | CFO | Sell | 1,653 | $18,497 |
| 2025-04-23 | Roivant Sciences Ltd. (ROIV) | CFO | Buy | 141,464 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-22